IQVIA Holdings Inc
NYSE:IQV
IQVIA Holdings Inc
NYSE:IQV
Price:
223.37 USD
0.55%
Market Closed
Updated:
May 4, 2024
IQVIA Holdings Inc
Operating Income
|
IQVIA Holdings Inc
Operating Income Peer Comparison
Comparables:
TMO
DHR
WST
MTD
A
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Operating Income
$661.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
See Also
What is IQVIA Holdings Inc's Operating Income?
Operating Income
2.1B
USD
2.1B
USD
Based on the financial report for Dec 31, 2023, IQVIA Holdings Inc's Operating Income amounts to 2.1B USD.
What is IQVIA Holdings Inc's Operating Income growth rate?
Operating Income CAGR 10Y
16%
16%
Over the last year, the Operating Income growth was 13%. The average annual Operating Income growth rates for IQVIA Holdings Inc have been 38% over the past three years , 21% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
